|
1
|
Aoyagi T, Terracina KP, Raza A and Takabe
K: Current treatment options for colon cancer peritoneal
carcinomatosis. World J Gastroenterol. 20:12493–12500.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Glehen O, Kwiatkowski F, Sugarbaker PH,
Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F,
Quenet F, et al: Cytoreductive surgery combined with perioperative
intraperitoneal chemotherapy for the management of peritoneal
carcinomatosis from colorectal cancer: A multi-institutional study.
J Oncol. 22:3284–3292. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chu DZ, Lang NP, Thompson C, Osteen PK and
Westbrook KC: Peritoneal carcinomatosis in nongynecologic
malignancy. A prospective study of prognostic factors. Cancer.
63:364–367. 1989.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Köhne CH, Cunningham D, Di Costanzo F,
Glimelius B, Blijham G, Aranda E, Scheithauer W, Rougier P, Palmer
M, Wils J, et al: Clinical determinants of survival in patients
with 5-fluorouracil-based treatment for metastatic colorectal
cancer: Results of a multivariate analysis of 3825 patients. Ann
Oncol. 13:308–317. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Verwaal VJ, van Ruth S, de Bree E, van
Sloothen GW, van Tinteren H, Boot H and Zoetmulder FA: Randomized
trial of cytoreduction and hyperthermic intraperitoneal
chemotherapy versus systemic chemotherapy and palliative surgery in
patients with peritoneal carcinomatosis of colorectal cancer. J
Clin Oncol. 21:3737–3743. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sugarbaker PH: Peritoneal metastases from
gastrointestinal cancer. Curr Oncol Rep. 20(62)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rettenmaier MA, Mendivil AA, Gray CM,
Chapman AP, Stone MK, Tinnerman EJ and Goldstein BH:
Intra-abdominal temperature distribution during consolidation
hyperthermic intraperitoneal chemotherapy with carboplatin in the
treatment of advanced stage ovarian carcinoma. Int J Hyperthermia.
31:396–402. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Goldenshluger M, Zippel D, Ben-Yaacov A,
Dux J, Yalon T, Zendel A, Rayman S, Mor E, Berkenstadt H,
Fogel-Grinvald H, et al: Core body temperature but not
intraabdominal pressure predicts postoperative complications
following closed-system hyperthermic intraperitoneal chemotherapy
(HIPEC) administration. Ann Surg Oncol. 25:660–666. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
de Andrade Mello P, Bian S, Savio LEB,
Zhang H, Zhang J, Junger W, Wink MR, Lenz G, Buffon A, Wu Y and
Robson SC: Hyperthermia and associated changes in membrane fluidity
potentiate P2X7 activation to promote tumor cell death. Oncotarget.
8:67254–67268. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li DY, Tang YP, Zhao LY, Geng CY and Tang
JT: Antitumor effect and immune response induced by local
hyperthermia in B16 murine melanoma: Effect of thermal dose. Oncol
Lett. 4:711–718. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zivanovic O, Chi DS, Filippova O, Randall
LM, Bristow RE and O'Cearbhaill RE: It's time to warm up to
hyperthermic intraperitoneal chemotherapy for patients with ovarian
cancer. Gynecol Oncol. 151:555–561. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Muckle DS and Dickson JA: The selective
inhibitory effect of hyperthermia on the metabolism and growth of
malignant cells. Br J Cancer. 25:771–778. 1971.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Seifert G, Budach V, Keilholz U, Wust P,
Eggert A and Ghadjar P: Regional hyperthermia combined with
chemotherapy in paediatric, adolescent and young adult patients:
Current and future perspectives. Radiat Oncol.
11(65)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sugarbaker PH: Laboratory and clinical
basis for hyperthermia as a component of intracavitary
chemotherapy. Int J Hyperthermia. 23:431–442. 2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Khosrawipour T, Schubert J, Kulas J,
Migdal P, Arafkas M, Bania J and Khosrawipour V: Creating
nanocrystallized chemotherapy: The differences in pressurized
aerosol chemotherapy (PAC) via intracavitary (IAG) and
extracavitary aerosol generation (EAG) regarding particle
generation, morphology and structure. J Cancer. 11:1308–1314.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Khosrawipour V, Reinhard S, Martino A,
Khosrawipour T, Arafkas M and Mikolajczyk A: Increased tissue
penetration of doxorubicin in pressurized intraperitoneal aerosol
chemotherapy (PIPAC) after High-Intensity Ultrasound (HIUS). Int J
Surg Oncol. 2019(6185313)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Schubert J, Khosrawipour T, Pigazzi A,
Kulas J, Bania J, Migdal P, Arafkas M and Khosrawipour V:
Evaluation of Cell-detaching Effect of EDTA in combination with
oxaliplatin for a possible application in HIPEC after cytoreductive
surgery: A preliminary in-vitro study. Curr Pharm Des.
25:4813–4819. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mikolajczyk A, Khosrawipour V, Schubert J,
Plociennik M, Nowak K, Fahr C, Chaudhry H and Khosrawipour T:
Feasibility and characteristics of pressurized aerosol chemotherapy
(PAC) in the bladder as a therapeutical option in early-stage
urinary bladder cancer. In Vivo. 32:1369–1372. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Khosrawipour V, Mikolajczyk A, Paslawski
R, Plociennik M, Nowak K, Kulas J, Arafkas M and Khosrawipour T:
Intrathoracic aerosol chemotherapy via spray-catheter. Mol Clin
Oncol. 12:350–354. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Khosrawipour V, Bellendorf A, Khosrawipour
C, Hedayat-Pour Y, Diaz-Carballo D, Förster E, Mücke R, Kabakci B,
Adamietz IA and Fakhrian K: Irradiation does not increase the
penetration depth of doxorubicin in normal tissue after pressurized
intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model.
In Vivo. 30:593–597. 2016.PubMed/NCBI
|
|
21
|
Khosrawipour V, Giger-Pabst U,
Khosrawipour T, Pour YH, Diaz-Carballo D, Förster E, Böse-Ribeiro
H, Adamietz IA, Zieren J and Fakhrian K: Effect of irradiation on
tissue penetration depth of doxorubicin after pressurized
intra-peritoneal aerosol chemotherapy (PIPAC) in a novel ex-vivo
model. J Cancer. 7:910–914. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Khosrawipour V, Khosrawipour T,
Hedayat-Pour Y, Diaz-Carballo D, Bellendorf A, Böse-Ribeiro H,
Mücke R, Mohanaraja N, Adamietz IA and Fakhrian K: Effect of
Whole-abdominal irradiation on penetration depth of doxorubicin in
normal tissue after pressurized intraperitoneal aerosol
chemotherapy (PIPAC) in a post-mortem swine model. Anticancer Res.
37:1677–1680. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mikolajczyk A, Khosrawipour V, Schubert J,
Grzesiak J, Chaudhry H, Pigazzi A and Khosrawipour T: Effect of
liposomal doxorubicin in pressurized intra-peritoneal aerosol
chemotherapy (PIPAC). J Cancer. 9:4301–4305. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mikolajczyk A, Khosrawipour T, Kulas J,
Migdal P, Arafkas M, Nicpon J and Khosrawipour V: The structural
effect of high intensity ultrasound on peritoneal tissue: A
potential vehicle for targeting peritoneal metastases. BMC Cancer.
20(481)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mikolajczyk A, Khosrawipour T, Martino A,
Kulas J, Pieczka M, Zacharski M, Nicpon J and Khosrawipour V:
Enabling microparticle imprinting to achieve penetration and local
endurance in the peritoneum via high-intensity ultrasound (HIUS)
for the treatment of peritoneal metastasis. Int J Surg Oncol.
2020(9679385)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mikolajczyk A, Khosrawipour V, Kulas J,
Kocielek K, Migdal P, Arafkas M and Khosrawipour T: Release of
doxorubicin from its liposomal coating via high intensity
ultrasound. Mol Clin Oncol. 11:483–487. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mikolajczyk A, Khosrawipour V, Lau H, Li
S, Migdal P, Labbe MK, Kielan W, Nicpon J, Stieglitz S and
Khosrawipour T: Exploring the potential of taurolidine in inducing
mobilisation and detachment of colon cancer cells: A preliminary
in-vitro study. BMC Pharmacol Toxicol. 23(38)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Schubert J, Khosrawipour V, Chaudhry H,
Arafkas M, Knoefel WT, Pigazzi A and Khosrawipour T: Comparing the
cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the
proliferation of in vitro colon carcinoma cells following
pressurized intra-peritoneal aerosol chemotherapy (PIPAC). World J
Surg Oncol. 17(93)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wust P, Hildebrandt B, Sreenivasa G, Rau
B, Gellermann J, Riess H, Felix R and Schlag PM: Hyperthermia in
combined treatment of cancer. Lancet Oncol. 3:487–497.
2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cihoric N, Tsikkinis A, van Rhoon G,
Crezee H, Aebersold DM, Bodis S, Beck M, Nadobny J, Budach V, Wust
P and Ghadjar P: Hyperthermia-related clinical trials on cancer
treatment within the urihttp://ClinicalTrials.govsimpleClinicalTrials.gov
registry. Int J Hyperthermia. 31:609–614. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kok HP, Wust P, Stauffer PR, Bardati F,
van Rhoon GC and Crezee J: Current state of the art of regional
hyperthermia treatment planning: A review. Radiat Oncol.
10(196)2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Sajid MS, Mallick AS, Rimpel J, Bokari SA,
Cheek E and Baig MK: Effect of heated and humidified carbon dioxide
on patients after laparoscopic procedures: A meta-analysis. Surg
Laparosc Endosc Percutan Tech. 18:539–546. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dean M, Ramsay R, Heriot A, Mackay J,
Hiscock R and Lynch AC: Warmed, humidified CO2
insufflation benefits intraoperative core temperature during
laparoscopic surgery: A meta-analysis. Asian J Endosc Surg.
10:128–136. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Binda MM: Humidification during
laparoscopic surgery: Overview of the clinical benefits of using
humidified gas during laparoscopic surgery. Arch Gynecol Obstet.
292:955–971. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Khosrawipour T, Schubert J, Khosrawipour
V, Chaudhry H, Grzesiak J, Arafkas M and Mikolajczyk A: Particle
stability and structure on the peritoneal surface in pressurized
intra-peritoneal aerosol chemotherapy (PIPAC) analysed by electron
microscopy: First evidence of a new physical concept for PIPAC.
Oncol Lett. 17:4921–4927. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Schubert J, Khosrawipour T, Reinhard S,
Arafkas M, Martino A, Bania J, Pieczka M, Pigazzi A and
Khosrawipour V: The concept of foam as a drug carrier for
intraperitoneal chemotherapy, feasibility, cytotoxicity and
characteristics. Sci Rep. 10(10341)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mikolajczyk A, Khosrawipour V, Schubert J,
Chaudhry H, Pigazzi A and Khosrawipour T: Particle stability during
pressurized intra-peritoneal aerosol chemotherapy (PIPAC).
Anticancer Res. 38:4645–4649. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Diakun A, Khosrawipour T,
Mikolajczyk-Martinez A, Nicpoń J, Kiełbowicz Z, Prządka P, Liszka
B, Kielan W, Zielinski K, Migdal P, et al: The onset of in-vivo
dehydration in gas-based intraperitoneal hyperthermia and its
cytotoxic effects on colon cancer cells. Front Oncol.
12(927714)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Diakun A, Khosrawipour T,
Mikolajczyk-Martinez A, Kuropka P, Nicpoń J, Kiełbowicz Z, Prządka
P, Liszka B, Li S, Lau H, et al: In-vivo thermodynamic exploration
of gas-based intraperitoneal hyperthermia. Front Oncol.
12(92572)2022.PubMed/NCBI View Article : Google Scholar
|
